Shows
Today's News Headlines from JIJIPRESSEmployee of Japan's Astellas Pharma Makes No Appeal against Spy Ruling in ChinaEmployee of Japan's Astellas Pharma Makes No Appeal against Spy Ruling in China2025-07-2900 min
PharmaSource PodcastHow Astellas Reset Research Procurement from 200 to 10 Suppliers“From Tokyo to Boston, we knew people had to see and feel the future we were building together. That is how you create lasting change.”Amber Meriwether, Director of Corporate Strategy at Astellas Pharma, has orchestrated one of the industry’s most dramatic supplier rationalisations whilst navigating complex cultural dynamics across seven global locations.In the latest PharmaSource podcast episode, Amber reveals how effective supplier rationalisation transcends traditional cost-cutting approaches, requiring sophisticated change management, cultural intelligence, and the ability to forge consensus amongst diverse scientific teams spanning multiple continents and research modalities.h...2025-07-2624 min
JIJI English News-時事通信英語ニュース-Astellas Employee Intends Not to Appeal Conviction in ChinaA Japanese employee of Astellas Pharma Inc. in his 60s, who was sentenced to three years and six months in prison for espionage in China on Wednesday, has no intention to appeal the ruling for now, informed sources said Saturday.2025-07-1900 min
Citeline PodcastsAstellas Doubles Down on Gene Therapy Despite Industry HeadwindsAstellas is doubling down on gene therapy while others retreat. Richard Wilson, SVP Primary Focus Lead, Genetic Regulation at Astellas, joins In Vivo to discuss why the company believes AAV technology will transform medicine despite current industry headwinds.
🎯 Key Topics:
- Why Astellas opened a massive new gene therapy manufacturing facility
- Building an end-to-end AAV platform from research to commercial
- Strategic partnerships driving CNS and rare disease programs
- Maintaining team morale in a challenging investment climate
- Regulatory outlook and the path to commercial success
Richard also plays a role in Astellas' West Coast Innovation Center and ser...2025-07-1531 min
OnPoint: The Medical Excellence Podcast16. Generative AI in Medical Affairs: Real Use Cases from Merck, Pfizer & AstellasFollowing a standing-room-only session at the 2025 MAPS Annual Meeting, Acceleration Point CEO Scott Thompson sits down with three industry leaders who are shaping how Generative AI is being applied inside Medical Affairs today—not in theory, but in practice.
Wendy Fraser (Merck), Annamaria Crisan (Pfizer), and Rishi Ohri (Astellas Pharma) share real-world examples, critical lessons, and hard-won truths from piloting Gen AI across Field Medical teams, Medical Information, HEOR, and Omnichannel. They discuss personal productivity, process improvement, clinical risks, compliance pitfalls, and how to build trust—both with your technology and your teams.
If you're expl...2025-06-1357 min
Pharma and BioTech DailyPharma and Biotech Daily: Catching up on the Latest in the IndustryGood morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The Summit's bispecific drug missed the survival endpoint in a global Phase III trial, but analysts remain optimistic about its potential to appeal to both Eastern and Western patient populations. Sanofi and Regeneron saw their shares tumble after a follow-up drug failed a Phase III COPD test. RFK Jr.'s report on health was found to have fake citations, casting doubt on its credibility. Astellas made a $1.5 billion bet on a Chinese collaboration for a cancer drug. In...2025-06-0200 min
OnPoint: The Medical Excellence Podcast15. Strategic Partnerships in Pharma: Medical Affairs & Commercial CollaborationIn this episode of the OnPoint Podcast, Scott Thompson welcomes Teri Michelini of Sanofi and Parker Richardson of Astellas Pharma to explore the evolving relationship between Medical Affairs and Commercial teams in pharma. As traditional silos and firewalls give way to transparency and strategic orchestration, what does true collaboration look like—and you get there without compromising compliance?
Teri and Parker draw from decades of experience to share real-world strategies for harmonizing roles, aligning messaging, and leveraging omnichannel innovations. From cross-functional planning and trust-building to creating scalable, tech-driven journeys for HCPs, this episode offers powerful insights for an...2025-05-2758 min
Career FootprintsMolly Campbell: Mastering complexityReed Smith alum Molly Campbell shares how her passion for learning novel and complex subjects and her powerful interactions with mentors enabled her to excel as a litigation associate and then partner at Reed Smith. She details how careful reflection and strong professional and personal relationships paved her path from trial lawyer to in-house counsel at Astellas Pharma advising on cutting-edge regulatory issues.
----more----
Transcript:
Intro: Welcome to the Reed Smith podcast, Career Footprints. In each episode of Career Footprints, we'll ask our guests, a Reed Smith alum, to share their career story...2025-02-1735 min
The Pharma Letter PodcastJapanese pharma in the UKIn this episode, we’ll take a look at the role of Japanese pharmaceutical groups in the UK, with Jackie Davis, general manager at Astellas Pharma.Tokyo-headquartered Astellas (TYO: 4503) has developed a strong portfolio in urology, oncology and immunology, most recently with US FDA approval for Vyloy (zolbetuximab), a key addition to its cancer treatments.It’s one of many Japanese companies with a strong presence in the UK, represented nationally by the Japanese Pharmaceutical Group, of which Jackie is the current chair.We’ll get into the details of a recent visit from t...2025-02-1419 min
EMJ GOLD: Pharma marketing, medical & moreBonus episode: Pharma review of the year 2024As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina Dempsey from Astellas and Elias Revonta, CEO of Orcason, who all return to the podcast to share their insights. Together, they’ll discuss the major trends, challenges and breakthroughs that shaped 2024, including advancements in oncology, gene therapy, rare diseases and the growing role of AI...2024-12-2423 min
The BioWorld Insider PodcastGene and cell therapies will propel innovation, says Astellas CCOGene and cell therapies will drive innovation for the next 10 years, Claus Zieler, the chief commercial officer at Astellas Pharma Inc., said in this episode of the BioWorld Insider podcast. Developers are on the cusp of breakthroughs because a gene can now be replaced “and that means we can potentially cure a disease rather than intervening in a disease.” Zieler also shared his thoughts on creating sustainable health care in aging societies, the innovation cycle gap between the U.S. and Europe, and how collaboration between business and government is critical in forging ahead in this wide-ranging discussion.2024-10-0727 min
Off Script: A Pharma Manufacturing PodcastEmergent donates 50k doses of mpox vaccine to Africa, FDA rejects Regeneron blood cancer bispecific antibody, China indicts Astellas exec for espionage [The good, the bad, the ugly]Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Emergent donates 50,000 doses of mpox vaccine to Africa
The bad — FDA rejects Regeneron blood cancer bispecific antibody
The ugly — China indicts Astellas exec for espionage
2024-08-2603 min
EMJ GOLD: Pharma marketing, medical & moreS07 E10: Astellas’ Tadaaki Taniguchi on how to challenge the status quoIn this season finale of the EMJ GOLD podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma, about how he strives to challenge the status quo in the pharmaceutical industry. The two discuss how Tadaaki’s time as a surgical oncologist has influenced his leadership style, how collaboration is key for making impacts for patients, the next game changers in cancer treatment and more. A little bit more on EMJ GOLD’s guest… Dr Tadaaki Taniguchi leads Astellas’ global team in identifying, discovering and developing new treatm...2024-08-1328 min
Xtalks Life Science PodcastFrom Symptoms to Solutions: Transforming Menopause Treatment with Marci English of Astellas PharmaIn this episode, Ayesha spoke with Marci English, Vice President and Head of BioPharma Development at Astellas Pharma about a groundbreaking new treatment that addresses the underlying mechanisms of menopause symptoms.
In May 2023, Astellas received FDA approval for fezolinetant (commercial name Veozah) for the treatment of moderate to severe vasomotor symptoms due to menopause. The therapy is the first nonhormonal neurokinin 3 (NK3) receptor antagonist approved to treat vasomotor symptoms associated with menopause, which include hot flashes and night sweats.
Tune into the episode to learn about the latest on fezolinetant one year after its approval...2024-07-1028 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 25
PeerView Clinical Pharmacology CME/CNE/CPE VideoRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 24
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 25
PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 24
PeerView Oncology & Hematology CME/CNE/CPE Video PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 24
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastRobert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care StrategiesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. CME/MOC/AAPA/IPCE credit will be available until February 25, 2025.Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies In support of improving patient care, this activity has been planned and implemented by...2024-03-011h 25
Empowered Patient PodcastPath to Developing Gene Therapies for Treating Rare Diseases with Ha Tran Astellas Pharma TRANSCRIPT Ha Tran, Medical Head, Cell and Gene Therapy at Astellas Pharma is developing gene therapy approaches to fight neuromuscular diseases, central nervous system disorders, and ophthalmology conditions. There is strong evidence that this approach can be a way to treat and possibly cure rare diseases. Ha explains the challenges of running gene therapy trials for rare diseases and the unique patient journey required to run a successful trial. Ha explains, "Currently, at Astellas, our platform is AAV gene therapy, which is a replacement. Additionally, in our early pipeline, we are looking at both gene therapy replacement and v...2024-02-2200 minEmpowered Patient PodcastPath to Developing Gene Therapies for Treating Rare Diseases with Ha Tran Astellas Pharma Ha Tran, Medical Head, Cell and Gene Therapy at Astellas Pharma is developing gene therapy approaches to fight neuromuscular diseases, central nervous system disorders, and ophthalmology conditions. There is strong evidence that this approach can be a way to treat and possibly cure rare diseases. Ha explains the challenges of running gene therapy trials for rare diseases and the unique patient journey required to run a successful trial. Ha explains, "Currently, at Astellas, our platform is AAV gene therapy, which is a replacement. Additionally, in our early pipeline, we are looking at both gene therapy replacement and v...2024-02-2220 min
PeerView Internal Medicine CME/CNE/CPE Audio PodcastAnjali Tiku Owens, MD - Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient OutcomesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QYG865. CME/MOC/NCPD/AAPA credit will be available until January 21, 2025.Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute...2024-02-101h 01PeerView Clinical Pharmacology CME/CNE/CPE VideoAnjali Tiku Owens, MD - Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient OutcomesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QYG865. CME/MOC/NCPD/AAPA credit will be available until January 21, 2025.Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute...2024-02-101h 01
PeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastAnjali Tiku Owens, MD - Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient OutcomesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QYG865. CME/MOC/NCPD/AAPA credit will be available until January 21, 2025.Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute...2024-02-101h 01
PeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastAnjali Tiku Owens, MD - Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient OutcomesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QYG865. CME/MOC/NCPD/AAPA credit will be available until January 21, 2025.Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute...2024-02-101h 01PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastAnjali Tiku Owens, MD - Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient OutcomesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QYG865. CME/MOC/NCPD/AAPA credit will be available until January 21, 2025.Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute...2024-02-101h 01
PeerView Internal Medicine CME/CNE/CPE Video PodcastAnjali Tiku Owens, MD - Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient OutcomesThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QYG865. CME/MOC/NCPD/AAPA credit will be available until January 21, 2025.Calling Primary Care Partners to Action in Hypertrophic Cardiomyopathy: Shortening the Time to Diagnosis for Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute...2024-02-101h 01PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastJaffer A. Ajani, MD, FASCO - Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until January 9, 2025.Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining Care In support of improving patient care, PVI, PeerView Institute...2024-02-011h 07PeerView Clinical Pharmacology CME/CNE/CPE VideoJaffer A. Ajani, MD, FASCO - Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until January 9, 2025.Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining Care In support of improving patient care, PVI, PeerView Institute...2024-02-011h 06PeerView Oncology & Hematology CME/CNE/CPE Video PodcastJaffer A. Ajani, MD, FASCO - Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until January 9, 2025.Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining Care In support of improving patient care, PVI, PeerView Institute...2024-02-011h 06
PeerView Gastroenterology CME/CNE/CPE Audio PodcastJaffer A. Ajani, MD, FASCO - Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until January 9, 2025.Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining Care In support of improving patient care, PVI, PeerView Institute...2024-02-011h 07
PeerView Gastroenterology CME/CNE/CPE Video PodcastJaffer A. Ajani, MD, FASCO - Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until January 9, 2025.Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining Care In support of improving patient care, PVI, PeerView Institute...2024-02-011h 06PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastJaffer A. Ajani, MD, FASCO - Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining CareThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZKG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until January 9, 2025.Looking Beyond the Horizon in Gastroesophageal Cancers: Updated Evidence on How Systemic Therapies Are Redefining Care In support of improving patient care, PVI, PeerView Institute...2024-02-011h 07PeerView Clinical Pharmacology CME/CNE/CPE VideoSergio A. Giralt, MD, FACP and Selina Luger, MD, FRCPC - Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicineThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/MQE865. CME credit will be available until December 31, 2024.Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicinePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to...2024-01-182h 02PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastSergio A. Giralt, MD, FACP and Selina Luger, MD, FRCPC - Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicineThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/MQE865. CME credit will be available until December 31, 2024.Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicinePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to...2024-01-182h 03PeerView Oncology & Hematology CME/CNE/CPE Video PodcastSergio A. Giralt, MD, FACP and Selina Luger, MD, FRCPC - Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicineThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/MQE865. CME credit will be available until December 31, 2024.Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicinePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to...2024-01-182h 02PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastSergio A. Giralt, MD, FACP and Selina Luger, MD, FRCPC - Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicineThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/MQE865. CME credit will be available until December 31, 2024.Achieving Next-Level Care in AML: Conversations on Targeted Platforms, Emerging Immunotherapies, and Implications for Precision MedicinePenn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to...2024-01-182h 03PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Clinical Pharmacology CME/CNE/CPE VideoNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Oncology & Hematology CME/CNE/CPE Video PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Internal Medicine CME/CNE/CPE Video PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Internal Medicine CME/CNE/CPE Audio PodcastNikhil C. Munshi, MD - Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific OptionsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MGG865. CME/MOC/AAPA credit will be available until December 31, 2024.Raising the BCMA Standard in Multiple Myeloma: Strategies for Enhanced Care With Potent CAR-T and Bispecific Options In support of improving patient care, this activity has been planned and...2024-01-131h 54PeerView Internal Medicine CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Oncology & Hematology CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Clinical Pharmacology CME/CNE/CPE VideoNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04PeerView Internal Medicine CME/CNE/CPE Video PodcastNeal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease ContinuumThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MOC/AAPA credit will be available until December 31, 2024.Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute...2023-12-221h 04
The Power ShiftThe Power of Perseverance in Career Change - with Dr. Yuki Nehikare from AstellasHow can one persevere in the pursuit of a non clinical career?
Join Dr. Abeyna Bubbers-Jones and Dr. Yuki Nehikhare on this episode where they explore how Yuki made the transition from being a clinician to the pharma industry, currently working at Big Pharma company Astellas.
This episode is tailored for healthcare professionals contemplating a career transition, the hosts address common fears and struggles, offering valuable insights on breaking through barriers and leveraging clinical experience to thrive in the pharma industry.
Dr. Nehikhare shares his insights about networking and creating lasting connections at...2023-12-0234 min
Power to the PatientsIntegrating patient centricity culturally and operationally, with Dr. Anthony Yanni, Sr. VP and Head of Patient Centricity at AstellasIn this episode we delve into the topic of patient centricity in clinical trials with Dr. Anthony Yanni, Senior Vice President and Global Head of Patient-Centricity at Astellas Pharma Inc. Dr. Yanni shares what patient-centricity means for him and how it is integrated both operationally and culturally at Astellas.
We explore how specialized teams work collaboratively to transform patient information into practical solutions, and the conscious patient-awareness that is a fundamental part of every role at Astellas. You'll also discover some innovative programs that bring patient-centricity to life.
Topics Discussed:
(00:00:00) Introduction
(00:00:52) Dr. Yanni’s car...2023-11-2127 minXtalks Life Science PodcastLead Investigator Dr. Genevieve Neal-Perry Discusses New Trial Data for Astellas’ Menopause Drug Fezolinetant (Veozah)This episode features an interview with Dr. Genevieve Neal-Perry, MD, PhD, professor and chair at the UNC School of Medicine Department of Obstetrics and Gynecology, and lead investigator on a study investigating Astellas Pharma’s fezolinetant (Veozah), which received FDA approval in May this year for the treatment of moderate to severe vasomotor symptoms due to menopause.
It’s the first nonhormonal neurokinin 3 (NK3) receptor antagonist approved to treat vasomotor symptoms, which include hot flashes and night sweats, associated with menopause.
Dr. Neal-Perry spoke about some of the latest trial data for fezolinetant that was pres...2023-10-2522 minXtalks Life Science PodcastXtalks Speaks with Astellas Pharma’s VP & Head of BioPharma Development Marci English About Menopause Drug ApprovalThis episode features an interview with Marci English, Vice President and Head of BioPharma Development at Astellas Pharma, about the recent FDA approval of the company’s drug Veozah (fezolinetant) for the treatment of moderate to severe hot flashes and night sweats due to menopause.
Hormone replacement therapy (HRT) has been the conventional treatment for menopause-associated vasomotor symptoms, otherwise known as hot flashes and night sweats; however, not all women can receive hormone therapies. Apart from HRT, treatment options have been limited for the vasomotor symptoms of menopause and therefore, the approval of Veozah addresses a significant unm...2023-06-2819 min
Beyond Biotech - the podcast from LabiotechBeyond Biotech podcast 33: Astellas Pharma, Innovation Agency Lithuania, 4BaseBio1:10 Labiotech.eu news2:50 Innovation Agency Lithuania25:25 Astellas Pharma34:37 4basebioThis week, our guests are Romualda Stragienė, director at Innovation Agency Lithuania and Andrius Sliuzas, export key account manager of high tech industries at Innovation Agency Lithuania; 4basebio CEO Heikki Lanckriet; and Yoshitsugu Shitaka, chief scientific officer at Astellas.4basebio4basebio, a spinout of 2Invest AG in 2020, is a life sciences company engaged in the design, manufacture and supply of application-specific synthetic DNA or mRNA, as well as targeted non-viral vectors for the delivery of nucleic acid payloads, for u...2023-02-1045 min
OncotargetNovel Antibody Drug Conjugate Improves Murine Acute Myeloid LeukemiaListen to a blog summary of a trending research paper published by Oncotarget: "Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model."
_________________________________________________________
The average age of patients with acute myeloid leukemia (AML) is 67 years old. Older adults generally have a lower tolerance for treatments that exhibit high off-target toxicity. Additionally, chemotherapy-relapsed or -refractory (R/R) AML patients are often at an advanced stage of disease and are therefore more likely to have comorbidities that may reduce their tolerance for harsh treatments.
Thus, pharmaceutical AML drugs with...2023-01-0507 min
Stark IntegrityRare Qui Tam Jury False Claims Act Case: Learning Points Regarding FCA Cases Including Eli Lilly/Astellas Pharma VerdictSend us a textJury trials under the False Claims Act (FCA) can produce very wild outcomes. In this episode, Captain Integrity Bob Wade breaks down what went down in the recent Eli Lilly/Astellas Pharma case. Hear why jury trials under the FCA are extremely rare, there are large jury verdicts, an effective compliance program can reduce or eliminate the risk of going to court, how big a return the government can receive, and how a mistake could be considered fraud. Learn more at CaptainIntegrity.com2022-09-1421 min
Life Sciences Leadership With Jasmeet SawhneyPost-COVID Mindset — How the Modern Field Force Operations Must EvolveIn today’s episode, we are joined by Mehmet Bozbay, Head of Field Deployment, Incentives & Analytics at Astellas Pharma US. We discuss the evolution of the field force and how it plays into the success of sales reps. Mehmet talks about the shift seen since the pandemic and what areas need enhancing to create the proper execution and effectiveness for success. He talks about how the role of sales reps is evolving and where customers are expecting more. Tune in to learn how healthcare providers and sales reps are changing the game, where they are investing, and other tips on...2022-07-2716 minBeyond Biotech - the podcast from LabiotechBeyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg PharmaOn this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach, and Eric Moessinger, both partners at +ND Capital; and Louise Modis, chief scientific officer at Mogrify.Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company, has received ethics and competent authority approval to commence its lipopolysaccharide (LPS) human challenge clinical trial for POLB 001, a strain agnostic, small molecule immunomodulator which aims to address the unmet medical need for a treatment for severe influenza.Biopharma company Mogrify Limited, and Japanese regenerative medicine fi...2022-07-2246 min
Disease awareness5. Permanent Skade - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Noen bruker lengre tid enn andre på å be om hjelp, og det kan f.eks ende opp med at en må bruke bleie på natten. Har...2022-02-0108 minDisease awareness1. Bevegelsesinkontinens - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Er du en av de som sliter med at du tisser på løpetur, på trampoline eller når du nyser? Da har du kanskje bev...2022-02-0108 minDisease awareness2. Hastverkslekkasje - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Har du opplevd at du må tisse ofte og veldig plutselig, og at det ikke er mulig å holde seg? I denne episoden snakker programleder Siri Kris...2022-02-0108 minDisease awareness3. OAB Livsstilsråd - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Å slite med å holde seg, å måtte tisse ofte eller plutselig kan være utfordrende, men hva kan du gjøre selv? I denne episoden snakker urolo...2022-02-0109 minDisease awareness4. LUTS - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Planlegger du ditt sosiale liv basert på om det er toalett tilgjengelig, eller er du mye oppe og tisser på natten? Da kan du kanskje k...2022-02-0110 minDisease awareness6. Unge Med Urinveisplager - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Men kan problemene også oppstå i ung alder? Hva kan du gjøre om du f.eks kan kjenne på at du må tisse oftere enn a...2022-02-0109 minDisease awareness7. OAB Skam, Redusert Sosialt Liv - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Kvier du deg for å si ifra til vennene dine om plagene du har, og fører det til at du trekker deg unna? Kjenner du på ska...2022-02-0108 minDisease awareness8. Få Hjelp - TISSETRENGTEn stor andel av den norske, voksne befolkningen sliter med plager eller symptomer knyttet til urinveiene. I denne podkasten får vi høre historier fra mennesker som sliter med slike plager, og får både tips, triks og råd om hvordan og når en skal oppsøke hjelp. Podkasten er laget av Astellas Pharma, og produsert av Klynge.En stor andel av den norske, voksne befolkningen sliter med plager knyttet til urinveiene. Velger du, eller noen du kjenner, å ikke oppsøke hjelp til tross for plager? Her får du svar på hvor og når du skal be o...2022-02-0109 min
Disease awarenessOta Puheeksi Part 1 Yliaktiivinen Rakko (OAB)Yliaktiivinen rakko voi vaivata sekä miehiä että naisia. Tässä podcastissa kokemuksistaan kertoo Ritva.ID: URO_2021_0101_FIPublished by Astellas Pharma a/s whose registered address is Hatsinanpuisto 8, 02600 Espoo, Finland. If you have any questions about this podcast or wish to contact us for any other reason, please do so via kontakt.fi@astellas.com2021-11-1710 min
Urgent MattersEpisode 4: OAB in the Female Population (ft. Prof. Linda Cardozo, UK)The nature of OAB management has been evolving gradually over time, with various strategies being employed in order to effectively manage OAB. There are many unique challenges and complexities associated with the management of OAB in women, and this episode will focus on OAB in women from diagnosis to treatment. Presented by leading urogynecologist, Prof. Linda Cardozo, this episode will cover a broad range of topics from patient attitudes to OAB treatments.Disclaimer:This presentation include products/indications which may not be approved in your country. Physicians should take into account the patient’s individual ci...2021-11-1531 min
Urgent MattersEpisode 5: OAB and Mental Health (ft. Prof Tufan Tarcan, Turkey)Mental health associations with OAB are widely acknowledged to impact patient outcomes, and there are clear links between OAB undermanagement and key mental health issues such as anxiety, self esteem issues and depression. With many countries beginning to invest significantly in mental health support and acknowledge its role in quality of life, understanding OAB-related mental health is critical. This episode will explore the nature of mental health issues within OAB, how these can be addressed, and why this is a pressing issue as populations age across the world.Disclaimer:This presentation include products/indications which...2021-11-1531 min
Urgent MattersEpisode 10: Lifelong Care & Geriatrics (ft. Prof. Adrian Wagg, Canada)The management of OAB increases in complexity as a patient becomes older. This can be due a number of factors, including the number of conditions an older patient needs to managed and the increasing severity of these conditions. In particular, cognitive impairment has become a major issue that has been identified among older OAB patients, with OAB being associated with measurably slower cognative responses. This episode will focus on the latest thinking on how to approach this OAB and lifelong care, and what is being done to address this issue as the geriatric population grows.Disclaimer:2021-11-1515 min
Urgent MattersEpisode 9: OAB Management – Ways to Move Forward (ft. Prof. Marcus Drake, UK)Effective management of urinary incontinence (UI) is influenced by patients’ help-seeking behaviours as well as which services are offered by healthcare professionals. To increase awareness, it is important to understand the knowledge, attitudes and beliefs of healthcare practitioners towards urinary incontinence management. This episode will explore varying attitudes to OAB diagnosis and management, and what more can be done to positively influence physician behaviour towards management. In particular, this episode will focus on how technological advances can change OAB management, and the impact this can have.Disclaimer:This presentation include products/indications which may not be...2021-11-1523 min
Urgent MattersEpisode 8: OAB in the Male Population (ft. Dr. James Urry, South Africa)Diagnosis and management of OAB among males can be challenging, especially given the inherent overlap in symptoms observed with Benign Prostate Hyperplasia (BPH). BPH is diagnosed and treated more frequently than OAB; however, the differences between diagnosis and treatment patterns for the two conditions highlight the potential undertreatment of OAB and misdirection of therapy for men. This episode explores various aspects of OAB in males, focusing on its unique characteristics within this population.Disclaimer:This presentation include products/indications which may not be approved in your country. Physicians should take into account the patient’s in...2021-11-1530 min
Urgent MattersEpisode 7: OAB Awareness in Primary Care (ft. Prof. Philip Van Kerrebroeck, Netherlands)Although there have been significant advances in OAB treatments, OAB is significantly under-recognised and under-treated within the primary care setting. It is well established that there is a high “willingness to learn” about OAB management within primary care, and that educational activities can have a lasting impact on clinical practice. This episode will explore the motivation for primary care physicians to learn about OAB, the impact continuing education can have, and how trends in OAB management can impact how primary care physicians care for OAB patients.Disclaimer:This presentation include products/indications which may not be a...2021-11-1522 min
Urgent MattersEpisode 3: Mobile Health Apps in OAB (ft. Prof. Cristiano Gomes, Brazil)There has been much focus recently into the current state of mHealth tools for urinary continence management, with much attention paid to how digital technology can address the changing nature of UI management in Brazil. Many have recently been calling for a new generation of user- centered mHealth apps that can empower OAB patients through a focus on exercise programs, tailored educational content and ability to track patient- reported symptoms. This episode covers how mHealth is used in Brazil, and explores a practicing urologists’ views on using this technology, what improvements can be made, and what the outlook looks li...2021-11-1518 min
Urgent MattersEpisode 6: Advances in Managing OAB (ft. Prof. Hashim Hashim, UK)Growing appreciation of OAB as a prevalent and impactful condition has spurred interest in advancing OAB management. These exciting advancements will have a significant impact on patient outcomes, which is especially critical as ageing populations grow. This episode covers an overview of OAB interventions, including non-invasive approaches, pharmacological treatments, and surgical interventions. In addition the episode will also touch upon what more can be done to improve OAB care and key trends in OAB management.Disclaimer:This presentation include products/indications which may not be approved in your country. Physicians should take into account the...2021-11-1524 min
Healthcare and Higher13. Stacey Tannenbaum - Senior Director of Pharmacometrics, U.S. at Astellas PharmaDr. Stacey Tannenbaum is the Senior Director of Pharmacometrics, U.S. at Astellas Pharma. She leads a team of clinical pharmacologists, statisticians, engineers, and data management experts who help quantify drug, disease and trial information that aid in drug development and regulatory decisions. Dr. Tannenbaum earned her Ph.D in Pharmaceutical Sciences and Applied Mathematics from the University of Arizona and completed a post-doctoral fellowship at the Center for Drug Development Science at Georgetown University. Prior to joining Astellas, she spent 8.5 years in the Modeling and Simulation group at Novartis. She currently holds faculty positions at the University of...2021-08-2055 min
Leaders in Pharmaceutical Business Intelligence (LPBI) GroupValue for Patients – Turning Advances in Science: A Case Study of a Leading Global Pharmaceutical Company – Astellas Pharma Inc.This episode is also available as a blog post: http://pharmaceuticalintelligence.com/2016/08/24/value-for-patients-turning-advances-in-science-a-case-study-of-a-leading-global-pharmaceutical-company-astellas-pharma-inc/2021-07-1318 min
Canadian Urological Association (CUA)Milestones in Advanced Bladder CancerPodcast Host Disclosures:Dr. Alimohamed has had a consulting or advisory role with Astellas Pharma, AstraZeneca, Janssen, Merck, Pfizer, and Sanofi Canada.Dr. Lalani has received honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche/Genentech, and TerSera; has had a consulting or advisory role with Abbvie, Astellas Pharma, Bayer, Bristol-Myers Squibb, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche/Genentech, and TerSera; and has received research funding from Bristol-Myers Squibb (Inst), Ipsen, Novartis, and Roche.Accreditation:This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance...2021-07-1227 min
Urgent MattersEpisode 2: OAB During the COVID-19 Pandemic (ft. Prof. Chris Chapple, UK)The UK ranked among the worst hit countries for Covid-19 in Europe, and the severity of the pandemic required recurrent lockdown measures to be put in place. Prof. Chris Chapple (UK) describes what was a dramatic shift in access to care for OAB patients, including disruption of surgical procedures and limited access to diagnostic services. This episode will look at the impact of the pandemic on OAB care, focusing outpatient services management, patients’ quality of life and other potentially serious health risks. Despite the pandemic, use of telemedicine increased, and this is seen as a promising tool to help ma...2021-06-1613 min
Urgent MattersEpisode 1: An Overview to Overactive Bladder (ft. Prof. Chris Chapple, UK)Prof. Paul Abrams and Prof. Christopher Chapple provide an overview Overactive Bladder (OAB), covering a range of topics, including the pathophysiology of OAB, aetiology of OAB, how it is diagnosed, general overview to management, epidemiology and how OAB has become a more urgent focus.Disclaimer:This presentation include products/indications which may not be approved in your country. Physicians should take into account the patient’s individual circumstances and consult the approved product information before prescribing.Astellas’ products availability, starting dose and indications may vary from country to country. These presentations are prepared sole...2021-06-1624 min
Disease awarenessLægen i øretHar du svært ved at holde på vandet?Så lyt med og hør lægens råd til, hvad du kan gøre,når vandladningen driller. Godkendelsesnummer: URO_2021_00342_DKPubliceret af Astellas Pharma a/s, hvis registrerede adresse er Arne Jacobsens Allé 15, 2300 København S.Hvis du har spørgsmål om vores podcast, brugsbetingelser eller ønsker at kontakte os af enhver anden årsag, bedes du gøre det via kontakt.dk@astellas.com.2021-05-0519 min
Disease awarenessEp. 7 Fremtiden - NyretransplantertI denne episoden tar vi opp temaer som:• Jobb• Jobbintervju• Venner og kjæreste• Barnehagebarn og sykdom• Graviditet• Amming • Prevensjon• KjønnssykdomMed i episoden er:Guro Helene Sørdalen, NyretransplantertStig Arne Kjellevold, Nefrolog, Nyreseksjonen, Sykehuset i Vestfold HF, TønsbergGuri Bårdstu Majak, Gynekolog, Kvinneklinikken, OUS, Ullevål sykehusTX_2020_0009_NO 08/2020Publisert av Astellas Pharma, som er registrert med adresse Hagaløkkveien 26, 1383 Asker.Hvis du har spørsmål angående podkasten, brukerbetingelsene eller ønsker å ta kontakt med oss, send mail til kontakt.no@astellas.com2020-11-0931 min
Disease awarenessEp. 6 Hverdagen fortsetter - NyretransplantertI denne episoden tar vi opp temaer som: • Trening• Toppidrett• Plastisk kirurgi • Tatovering• Tannlege• KjæledyrMed i episoden er: Guro Helene Sørdalen, NyretransplantertStig Arne Kjellevold, Nefrolog, Nyreseksjonen, Sykehuset i Vestfold HF, TønsbergTX_2020_0008_NO 08/2020Publisert av Astellas Pharma, som er registrert med adresse Hagaløkkveien 26, 1383 Asker.Hvis du har spørsmål angående podkasten, brukerbetingelsene eller ønsker å ta kontakt med oss, send mail til kontakt.no@astellas.com2020-11-0918 minDisease awarenessEp. 5 Hverdagen - NyretransplantertI denne episoden tar vi opp temaer som: • Skole• Drømmejobben• Mat• Tilsetningsstoffer, e-stoffer og vitaminerMed i episoden er: Guro Helene Sørdalen, NyretransplantertStig Arne Kjellevold, Nefrolog, Nyreseksjonen, Sykehuset i Vestfold HF, TønsbergTX_2020_0007_NO 08/2020Publisert av Astellas Pharma, som er registrert med adresse Hagaløkkveien 26, 1383 Asker.Hvis du har spørsmål angående podkasten, brukerbetingelsene eller ønsker å ta kontakt med oss, send mail til kontakt.no@astella.com2020-11-0923 minDisease awarenessEp. 4 Ferie og fest - NyretransplantertI denne episoden tar vi opp temaer som: • Medisiner ved tidssoner• Vaksine• Mat i utlandet • Medisiner på reise• Sol• Alkohol/Røyk/snusMed i episoden er:Ena Marie Roland, nyretransplantertNikolai Raabye Haugen, nyretransplantertGuro Helene Sørdalen, NyretransplantertHege Kampen Pihlstrøm, Nefrolog, Avdeling for Kirurgi, Transplantasjon og Inflammasjonsmedisin, nyreseksjonen, RikshospitaletTX_2020_0006_NO 08/2020Publisert av Astellas Pharma, som er registrert med adresse Hagaløkkveien 26, 1383 Asker.Hvis du har spørsmål angående podkasten, brukerbetingelsene eller ønsker å ta kontakt med oss, send mail til kontakt.no@astellas.com2020-11-0918 minDisease awarenessEp. 3 Livet som før? - NyretransplantertI denne episoden tar vi opp temaer som:• Medisiner• Bivirkninger• Kontroller hos legen• Medisiner ved oppkast og diarè• Glemt en dose? • AvstøtningMed i episoden er: Ena Marie Roland, nyretransplantertNikolai Raabye Haugen, nyretransplantertHege Kampen Pihlstrøm, Avdeling for Kirurgi, Transplantasjon og Inflammasjonsmedisin, nyreseksjonen, RikshospitaletMarte Theie Gustavsen, farmasøyt, Seksjon for Nyremedisin, Avdeling for Transplantasjonsmedisin. RikshopitaletTX_2020_0005_NO 08/2020Publisert av Astellas Pharma, som er registrert med adresse Hagaløkkveien 26, 1383 Asker.Hvis du har spørsmål angående podkasten, brukerbetingelsene eller ønsker å ta kontakt med oss, send mail til kontakt.no@astellas.com2020-11-0922 minDisease awarenessEp. 2 På Sykehuset - NyretransplantertI denne episoden tar vi opp temaer som:• Hva skjer når du ankommer Rikshospitalet?• Undersøkelser før operasjon• Hvem kan være med på sykehuset?• Operasjonen• Dagene etter operasjonMed i episoden er: Nikolai Raabye Haugen, nyretransplantertTone Vidnes, Fagutviklingssykepleier, Avdeling for transplantasjonsmedisin, sengepost transplantasjon, RikshospitaletMorten Heier Skauby, Overlege, Seksj. For Transplantasjonskirurgi, Klinikk for Kirurgi, Inflammasjonsmedisin og Transplantasjon, RikshospitaletFanny Bruserud, koordinerende sykepleier for de som står på transplantasjonslisten, RikshospitaletTX_2020_0004_NO 08-2020Publisert av Astellas Pharma, som er registrert med adresse Hagaløkkveien 26, 1383 Asker.Hvis du har spørsmål angående podkasten, brukerbetingelsene eller ønsker å ta kontakt med oss, send mail til kontakt.n2020-11-0914 minDisease awarenessEP. 1 Telefonen ringer! - NyretransplantertI denne episoden tar vi opp temaer som:• Ventetiden • Transport til Rikshospitalet• Restriksjoner ved å stå på en transplantasjonsliste• Transplantasjonslisten• DonormatchMed i episoden er:Nikolai Raabye Haugen, nyretransplantertFanny Bruserud, koordinerende sykepleier for de som står på transplantasjonslisten, RikshospitaletMorten Heier Skauby, Overlege, Seksj. For Transplantasjonskirurgi, Klinikk for Kirurgi, Inflammasjonsmedisin og Transplantasjon, RikshospitaletID: TX_2020_0003_NO 06-2020Publisert av Astellas Pharma, som er registrert med adresse Hagaløkkveien 26, 1383 Asker.Hvis du har spørsmål angående podkasten, brukerbetingelsene eller ønsker å ta kontakt med oss, send mail til kontakt.no@astellas .com2020-11-0916 min
Understanding EdgeIs Pharma Reentering a Golden Age of Innovation?Innovation and productivity in the pharmaceutical industry has been in steady decline for decades. However, we believe the industry is poised for a comeback.
The views expressed are those of Diamond Hill as of September 2020 and are subject to change. These opinions are not intended to be a forecast of future events, a guarantee of results, or investment advice.
As of July 31, 2020, Diamond Hill owned equity shares of Gilead Sciences, Inc., GlaxoSmithKline PLC, Pfizer, Inc., Alphabet, Inc. (Classes A&C), Novartis AG, Astellas Pharma, Inc. and Roche Holdings AG.
This material is for...2020-09-1126 min
Podcast on PodcastingHow Astellas Pharma Created a Scalable Podcast StrategyIn this episode, hear the success story of Josh Williamson, the Senior Technical Analyst for Commercial Learning and Development at Astellas Pharma US, who sought to maximize field representative's windshield time. Not only did Josh want to take advantage of a broader organization need, he was also interested in finding a solution that was scalable so that he could additionally support the needs of their learning and development organization. Today, Astellas has 11 internal podcast shows available to its employees through uStudio. Listen to this episode to learn more about Josh's content strategy.
*The speaker is a paid employee...2020-06-1800 min
Podcast on PodcastingHow Astellas Pharma Created a Scalable Podcast StrategyIn this episode, hear the success story of Josh Williamson, the Senior Technical Analyst for Commercial Learning and Development at Astellas Pharma US, who sought to maximize field representative's windshield time. Not only did Josh want to take advantage of a broader organization need, he was also interested in finding a solution that was scalable so that he could additionally support the needs of their learning and development organization. Today, Astellas has 11 internal podcast shows available to its employees through uStudio. Listen to this episode to learn more about Josh's content strategy.
*The speaker is a paid employee of Astellas...2020-06-1833 min
The Real Chemistry PodcastChampioning Cultural Competency in Healthcare: Eloiza Domingo, Executive Director and Global Head of Engagement, Diversity & Inclusion of Astellas Pharma USCreating cultural competency within healthcare organizations is key for patients. Eloiza Domingo of Astellas Pharma US discusses the importance of cultural competency within the industry and unpacks how diversity and inclusion improves patient outcomes.2020-05-2124 minThe Real Chemistry PodcastChampioning Cultural Competency in Healthcare: Eloiza Domingo, Executive Director and Global Head of Engagement, Diversity & Inclusion of Astellas Pharma USCreating cultural competency within healthcare organizations is key for patients. Eloiza Domingo of Astellas Pharma US discusses the importance of cultural competency within the industry and unpacks how diversity and inclusion improves patient outcomes.2020-05-2124 min
The Real Chemistry PodcastLooking Beyond Treatment to Improve the Cancer Care Journey: Bill Rancic, Entrepreneur & Mark Reisenauer, SVP of Oncology at Astellas PharmaLooking beyond treatment is key to improving the cancer care journey. This week Entrepreneur Bill Rancic and Astellas Pharma's Oncology SVP Mark Reisenauer, discuss the challenges of being a caregiver and why they are excited about Astellas Oncology’s C3 Prize, a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine.2019-05-2323 minThe Real Chemistry PodcastLooking Beyond Treatment to Improve the Cancer Care Journey: Bill Rancic, Entrepreneur & Mark Reisenauer, SVP of Oncology at Astellas PharmaLooking beyond treatment is key to improving the cancer care journey. This week Entrepreneur Bill Rancic and Astellas Pharma's Oncology SVP Mark Reisenauer, discuss the challenges of being a caregiver and why they are excited about Astellas Oncology’s C3 Prize, a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine.2019-05-2323 min
HR LeadersRochelle Chopamba, SVP HR EMEA, Astellas PharmaEpisode #27 - We are joined by Rochelle Chopamba, SVP HR EMEA, Astellas Pharma. Watch the video footage from the podcast here: http://bit.ly/HRDLeadersPodcast.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.2017-11-0734 min
Datamonitor Healthcare Analyst Podcast6/16/2017Jared Wolff, Jack Allen, and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Topics covered in this episode include:
- Overview of data from Novartis's JULIET trial: CAR-T impact (KITE & JUNO) (0:45)
- Betrixiban's June 24th PDUFA (Portola) in prophylaxis of VTE (8:00)
- Effect of Xtandi (Pfizer/Astellas) PROSPER trial amendments on prostate cancer market dynamic (Zytiga -JNJ mentioned) (15:12)
- Scott Gottlieb's agenda as FDA commissioner: Five major policy points and the opioid epidemic (19:40)
To learn more about Datamonitor Healthcare and our offerings, visit:
https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare2017-06-1630 min